These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9563656)

  • 1. Detection of tumor-derived DNA in exfoliated cells of urine sediments with a novel quantitative PCR method based on allele-specific PCR.
    Yamada H; Kakehi Y; Okuno H; Yoshida O
    Cancer Lett; 1998 Apr; 126(1):111-8. PubMed ID: 9563656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique.
    Conejo JR; Parra T; Cantero M; Jiménez A; Granizo V; de Arriba G; Carballo F
    Clin Chem; 1998 Jul; 44(7):1570-2. PubMed ID: 9665446
    [No Abstract]   [Full Text] [Related]  

  • 3. Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clones.
    Stoehr R; Knuechel R; Boecker J; Blaszyk H; Schmitt R; Filbeck T; Hofstaedter F; Hartmann A
    Lab Invest; 2002 Nov; 82(11):1553-61. PubMed ID: 12429815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of p53 gene mutations in bladder cancers and urine samples.
    Sidransky D; Von Eschenbach A; Tsai YC; Jones P; Summerhayes I; Marshall F; Paul M; Green P; Hamilton SR; Frost P
    Science; 1991 May; 252(5006):706-9. PubMed ID: 2024123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
    Arlt VM; Schmeiser HH; Pfeifer GP
    Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.
    Curigliano G; Ferretti G; Flamini G; Goldhirsch A; de Braud F; Calabro MG; Mandaly M; Nole F; De Pas T; D'Addessi A; Cittadini A
    Anticancer Res; 2001; 21(4B):3015-20. PubMed ID: 11712804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the amplification refractory mutation allele-specific polymerase chain reaction system for sensitive and specific detection of p53 mutations in DNA.
    Low EO; Jones AM; Gibbins JR; Walker DM
    J Pathol; 2000 Mar; 190(4):512-5. PubMed ID: 10700003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens.
    Prescott JL; Montie J; Pugh TW; McHugh T; Veltri RW
    Cancer; 2001 Jun; 91(11):2127-35. PubMed ID: 11391594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutations in human urothelial carcinomas: analysis by immunohistochemistry and single-strand conformation polymorphism.
    Oyasu R; Nan L; Szumel RC; Kawamata H; Hirohashi S
    Mod Pathol; 1995 Feb; 8(2):170-6. PubMed ID: 7777479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues.
    Wilson VL; Wei Q; Wade KR; Chisa M; Bailey D; Kanstrup CM; Yin X; Jackson CM; Thompson B; Lee WR
    Mutat Res; 1999 Aug; 406(2-4):79-100. PubMed ID: 10479725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients.
    Ouhtit A; Ueda M; Nakazawa H; Ichihashi M; Dumaz N; Sarasin A; Yamasaki H
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):433-8. PubMed ID: 9184777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism.
    Sugano K; Tsutsumi M; Nakashima Y; Yamaguchi K; Ohkura H; Kakizoe T; Sekiya T
    Int J Cancer; 1997 Aug; 74(4):403-6. PubMed ID: 9291429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
    Schneider A; Borgnat S; Lang H; Régine O; Lindner V; Kassem M; Saussine C; Oudet P; Jacqmin D; Gaub MP
    Cancer Res; 2000 Aug; 60(16):4617-22. PubMed ID: 10969815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.